Nutex Health (NASDAQ:NUTX) Shares Down 7.1% – Here’s Why

Nutex Health Inc. (NASDAQ:NUTX)’s share price fell 7.1% during trading on Wednesday . The stock traded as low as $164.00 and last traded at $169.23. 51,367 shares were traded during mid-day trading, a decline of 66% from the average session volume of 151,826 shares. The stock had previously closed at $182.23.

Analyst Upgrades and Downgrades

NUTX has been the subject of several analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a report on Monday. Wall Street Zen raised shares of Nutex Health from a “buy” rating to a “strong-buy” rating in a research report on Friday, November 28th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.

Nutex Health Stock Down 9.7%

The stock has a market cap of $1.16 billion, a PE ratio of 8.90 and a beta of -0.08. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 3.18. The company has a 50 day moving average price of $143.02 and a two-hundred day moving average price of $116.24.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings data on Tuesday, November 18th. The company reported $7.76 EPS for the quarter, beating the consensus estimate of ($5.43) by $13.19. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.The company had revenue of $243.99 million for the quarter, compared to analysts’ expectations of $221.93 million.

Insider Activity at Nutex Health

In related news, CFO Jon Christian Bates acquired 750 shares of the firm’s stock in a transaction dated Tuesday, November 25th. The stock was purchased at an average cost of $136.71 per share, with a total value of $102,532.50. Following the completion of the acquisition, the chief financial officer directly owned 5,638 shares of the company’s stock, valued at approximately $770,770.98. This trade represents a 15.34% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. 36.92% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Nutex Health

A number of large investors have recently added to or reduced their stakes in NUTX. State of Alaska Department of Revenue purchased a new stake in Nutex Health during the 3rd quarter valued at $30,000. BNP Paribas Financial Markets grew its holdings in shares of Nutex Health by 966.7% in the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after acquiring an additional 290 shares during the period. Ameritas Investment Partners Inc. purchased a new stake in Nutex Health during the second quarter valued at $44,000. Police & Firemen s Retirement System of New Jersey bought a new position in Nutex Health in the second quarter valued at about $97,000. Finally, KLP Kapitalforvaltning AS purchased a new position in Nutex Health in the second quarter worth about $112,000. Institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.